Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jeff Chodakewitz"'
Autor:
Bindhu V. Karanam, Stephen Flach, Carol Addy, Sanjeev Kumar, Jeff Chodakewitz, David J. Schenk, Thomas Bateman, Dennis C. Dean, Aubrey Stoch, Hankun Li, Allen N. Jones, Matt Braun, John A. Wagner, Vijay Bhasker G. Reddy, Amanda Freeman, Susie Li, Andy Shiqiang Zhang
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems. 40(10)
Taranabant (N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide or MK-0364) is an orally active inverse agonist of the cannabinoid 1 (CB-1) receptor that was under development f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4076fb95f8c9db009af875688654f0cc
https://pubmed.ncbi.nlm.nih.gov/20722472
https://pubmed.ncbi.nlm.nih.gov/20722472
Autor:
Martin Danis, Jeff Chodakewitz, Ingibjörg Hilmarsdottir, Donald C. Neu, P. Gaxotte, Annick Datry, Mohamed Lyagoubi, Sylvestre Biligui, Rubén Mayorga-Sagastume, Marc Gentilini
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 88(3)
Ivermectin is highly effective against animal intestinal nematodes and is used in the treatment of onchocerciasis in humans. A study was undertaken to compare the efficacy of the drug with that of albendazole in the treatment of uncomplicated strongy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e98047cdc5a04abee225b9e2887c6e8a
https://pubmed.ncbi.nlm.nih.gov/7660457
https://pubmed.ncbi.nlm.nih.gov/7660457